<DOC>
	<DOCNO>NCT01718951</DOCNO>
	<brief_summary>To compare efficacy golimumab pamidronate treatment axial spondyloarthropathy</brief_summary>
	<brief_title>Golimumab Versus Pamidronate Treatment Axial Spondyloarthropathy : 48-week Trial</brief_title>
	<detailed_description>To compare efficacy golimumab pamidronate treatment non-radiological axial spondyloarthropathy</detailed_description>
	<mesh_term>Spondylarthropathies</mesh_term>
	<mesh_term>Spondylarthritis</mesh_term>
	<mesh_term>Antibodies , Monoclonal</mesh_term>
	<criteria>1 . Subjects great 18 year age 2 . Fulfilling late classification criterion axial spondyloarthropathy 3 . Active spondylitis define Bath Ankylosing Spondylitis Disease Activity Index ( BASDAI ) score 4 despite treatment nonsteroid antiinflammatory drug 3 month 1 . Major surgery ( include joint surgery ) within 8 week prior study entry 2 . History treatment antitumor necrosis factor agent investigational therapy within 12 month study entry 3 . Immunization live/attenuated vaccine within 4 week prior study entry 4 . Active current bacterial , viral , fungal , mycobacterial infection study entry 5 . Chronic hepatitis B hepatitis C carriers 6 . History malignancy , include solid tumor hemic malignancy 7 . History congestive heart failure 8 . History demyelinate disorder 9 . History peripheral neuropathy 10 . Pregnant woman lactate mother 11 . Baseline liver parenchymal enzyme elevate 2 time normal 12 . Absolute lymphocyte count less 500/mm3 13 . Serum creatinine level 200umol/L</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>spondyloarthropathy</keyword>
	<keyword>ankylose spondylitis</keyword>
</DOC>